106. クリオピリン関連周期熱症候群 Cryopyrin-associated periodic syndrome Clinical trials / Disease details

臨床試験数 : 42 / 薬物数 : 24 - (DrugBank : 4) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 48

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01045772 (ClinicalTrials.gov)	January 2009	7/1/2010	Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)	A Single-Centre, Open Label Study of the Safety and Tolerability of Rilonaceptin Subjects Living in ...	Muckle-Wells Syndrome;Schnitzler Syndrome	Drug: rilonacept	Charite University, Berlin, Germany	NULL	Completed	18 Years	N/A	Both	10	Phase 2	Germany
2	EUCTR2006-004290-97-DE (EUCTR)	19/12/2008	17/10/2006	A Single-Centre, Open Label Study of the Safety and Tolerability of Rilonaceptin Subjects Living in ...	A Single-Centre, Open Label Study of the Safety and Tolerability of Rilonaceptin Subjects Living in ...	The medical condition to be investigated was first described by Muckle and Wells 1962. The Muckle-We ...	Trade Name: Rilonacept	Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy	NULL	Not Recruiting			Female: yes Male: yes			Germany
3	NCT00288704 (ClinicalTrials.gov)	December 2005	6/2/2006	Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)	IL1T-AI-0505: A Multi-center, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, & ...	Familial Cold Autoinflammatory Syndrome (FCAS);Familial Cold Urticaria;Muckle-Wells Syndrome (MWS);G ...	Drug: rilonacept 160 mg;Drug: Placebo	Regeneron Pharmaceuticals	NULL	Completed	7 Years	N/A	All	104	Phase 3	United States

First Previous1Next Last